Hutchmed China Ltd ADR (HCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Cash Flows From Operating Activities | |||||
Net Income | 101,094 | -360,386 | -167,041 | -115,517 | -103,679 |
Depreciation Amortization | 8,207 | 8,664 | 7,190 | 6,061 | 4,942 |
Accounts receivable | -21,336 | -14,451 | -35,634 | -4,693 | -271 |
Accounts payable and accrued liabilities | -32,542 | 29,938 | 9,565 | 7,651 | -1,664 |
Other Working Capital | 71,146 | 58,704 | 32,458 | 29,273 | 16,105 |
Other Operating Activity | 92,689 | 8,932 | -50,761 | 15,159 | 3,655 |
Operating Cash Flow | $219,258 | $-268,599 | $-204,223 | $-62,066 | $-80,912 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -285,029 | 316,440 | -434,612 | -103,535 | 118,904 |
PPE Investments | -32,612 | -36,664 | -16,756 | -19,580 | -8,565 |
Net Acquisitions | -2,990 | N/A | N/A | N/A | 8,689 |
Sale Of Investment | N/A | 324 | N/A | N/A | N/A |
Other Investing Activity | 29,495 | 16,488 | 145,048 | -2,326 | 0 |
Investing Cash Flow | $-291,136 | $296,588 | $-306,320 | $-125,441 | $119,028 |
Cash Flows From Financing Activities | |||||
Debt Issued | 61,705 | 17,753 | N/A | N/A | 26,807 |
Debt Repayment | N/A | -26,923 | N/A | N/A | -26,923 |
Common Stock Issued | 5,094 | 174 | 717,319 | 318,934 | 251 |
Common Stock Repurchased | -9,071 | -48,084 | -27,309 | -12,904 | -346 |
Dividend Paid | -9,068 | -25,600 | -9,894 | -1,462 | -1,282 |
Other Financing Activity | 0 | -83 | -30,088 | -8,134 | 0 |
Financing Cash Flow | $48,660 | $-82,763 | $650,028 | $296,434 | $-1,493 |
Exchange Rate Effect | -6,471 | -9,490 | 2,427 | 5,546 | -1,502 |
Beginning Cash Position | 313,278 | 377,542 | 235,630 | 121,157 | 86,036 |
End Cash Position | 283,589 | 313,278 | 377,542 | 235,630 | 121,157 |
Net Cash Flow | $-29,689 | $-64,264 | $141,912 | $114,473 | $35,121 |
Free Cash Flow | |||||
Operating Cash Flow | 219,258 | -268,599 | -204,223 | -62,066 | -80,912 |
Capital Expenditure | -32,612 | -36,664 | -16,756 | -19,580 | -8,565 |
Free Cash Flow | 186,646 | -305,263 | -220,979 | -81,646 | -89,477 |